Imagion Biosystems Limited IBXXF
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 0.39% | 1,064.52% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.39% | 1,064.52% | |||
| Cost of Revenue | 0.39% | 11.47% | |||
| Gross Profit | -0.38% | 22.96% | |||
| SG&A Expenses | 0.39% | -22.38% | |||
| Depreciation & Amortization | 0.00% | -50.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.39% | -1.47% | |||
| Operating Income | -0.38% | 22.80% | |||
| Income Before Tax | -0.38% | 21.77% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -0.38% | 21.77% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.38% | 21.77% | |||
| EBIT | -0.38% | 22.80% | |||
| EBITDA | -0.40% | 22.74% | |||
| EPS Basic | 0.00% | 44.00% | |||
| Normalized Basic EPS | 0.00% | 40.00% | |||
| EPS Diluted | 0.00% | 44.00% | |||
| Normalized Diluted EPS | 0.00% | 40.00% | |||
| Average Basic Shares Outstanding | 0.00% | 38.71% | |||
| Average Diluted Shares Outstanding | 0.00% | 38.71% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||